Waldenström Macroglobulinemia, An Issue of Hematology/Oncology Clinics of North America
- 1st Edition, Volume 37-4 - June 30, 2023
- Latest edition
- Editors: Jorge J Castillo, Prashant Kapoor, Shayna Sarosiek
- Language: English
In this issue of Hematology/Oncology Clinics, guest editors Drs. Jorge J. Castillo, Prashant Kapoor, and Shayna Sarosiek bring their considerable expertise to the topic of… Read more
Purchase options
In this issue of Hematology/Oncology Clinics, guest editors Drs. Jorge J. Castillo, Prashant Kapoor, and Shayna Sarosiek bring their considerable expertise to the topic of Waldenström Macroglobulinemia. Top experts in the field provide a focused update on the biology, diagnosis and management, and novel therapies for patients with Waldenström macroglobulinemia, a rare blood cell cancer characterized by an excess of abnormal white blood cells in the bone marrow.
-
Contains 14 practice-oriented topics including clinical implications of genomic profile in Waldenström macroglobulinemia; chemoimmunotherapy regimens in the frontline management of Waldenström macroglobulinemia; management of relapsed or refractory Waldenström macroglobulinemia; evaluation and management of aggressive transformation in Waldenström macroglobulinemia; management of Waldenström macroglobulinemia in limited-resource settings; and more.
-
Provides in-depth clinical reviews of Waldenström macroglobulinemia, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Hematology, oncology
Clinical Implications of Genomic Profile in Waldenström Macroglobulinemia Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia Future Directions in the Frontline Management of Waldenström Macroglobulinemia The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia Novel Agents in Waldenström Macroglobulinemia Investigation and Management of Immunoglobulin M– and Waldenström-Associated Peripheral Neuropathies Evaluation and Management of Bing–Neel Syndrome Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia Management of Waldenström Macroglobulinemia in Limited-Resource Settings
- Edition: 1
- Latest edition
- Volume: 37-4
- Published: June 30, 2023
- Language: English
PK
Prashant Kapoor
Affiliations and expertise
Mayo ClinicSS
Shayna Sarosiek
Affiliations and expertise
Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute